Elaine Ullian, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 5,000 shares at $106.42 ($539K) on 2014-10-01, disclosed to the SEC on 2014-10-03.
Scheduled sale ($539k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $106.42 | 808 | $86K | 16.0% |
| 2 | $107.48 | 2,592 | $279K | 51.7% |
| 3 | $108.32 | 1,100 | $119K | 22.1% |
| 4 | $109.30 | 300 | $33K | 6.1% |
| 5 | $110.45 | 100 | $11K | 2.1% |
| 6 | $111.57 | 100 |
| $11K |
| 2.1% |
| Total | $107.74 avg | 5,000 | $539K | 100% |
| Filing → |
| HOLX | SELL | 2017-07-06 | $801K | — | Filing → |
| HOLX | SELL | 2017-06-06 | $786K | — | Filing → |
| HOLX | SELL | 2017-05-05 | $799K | — | Filing → |